Rapid and sensitive detection of UGT1A1 polymorphisms associated with irinotecan toxicity by a novel DNA microarray

由 Tsunedomi, Ryouichi, Hazama, Shoichi, Okayama, Naoko, Oka, Masaaki, Nagano, Hiroaki
發表在 Cancer Sci (2017)

Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy

由 Hazama, Shoichi, Tamada, Koji, Yamaguchi, Yoshiyuki, Kawakami, Yutaka, Nagano, Hiroaki
發表在 Ann Gastroenterol Surg (2018)

Novel Biomarkers for Personalized Cancer Immunotherapy

由 Shindo, Yoshitaro, Hazama, Shoichi, Tsunedomi, Ryouichi, Suzuki, Nobuaki, Nagano, Hiroaki
發表在 Cancers (Basel) (2019)

Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs

由 Hashimoto, Noriaki, Tsunedomi, Ryouichi, Yoshimura, Kiyoshi, Watanabe, Yusaku, Hazama, Shoichi, Oka, Masaaki
出版 2014

Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer

由 Kawamura, Junichiro, Sugiura, Fumiaki, Sukegawa, Yasushi, Yoshioka, Yasumasa, Hida, Jin-Ichi, Hazama, Shoichi, Okuno, Kiyotaka
發表在 Oncol Lett (2018)

Cytotoxic T lymphocyte response to peptide vaccination predicts survival in stage III colorectal cancer

由 Kawamura, Junichiro, Sugiura, Fumiaki, Sukegawa, Yasushi, Yoshioka, Yasumasa, Hida, Jin‐ichi, Hazama, Shoichi, Okuno, Kiyotaka
發表在 Cancer Sci (2018)

Relationship Between Cytokine Gene Polymorphisms and Risk of Postoperative Pneumonia with Esophageal Cancer

由 Sakamoto, Kazuhiko, Oka, Masaaki, Yoshino, Shigehumi, Hazama, Shoichi, Takeda, Shigeru, Yoshimura, Kiyoshi, Okayama, Naoko, Hinoda, Yuji
出版 2014

A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model

由 HIGASHI, KOSUKE, HAZAMA, SHOICHI, ARAKI, ATSUHIRO, YOSHIMURA, KIYOSHI, IIZUKA, NORIO, YOSHINO, SHIGEFUMI, NOMA, TAKAFUMI, OKA, MASAKI
出版 2014

Frizzled-7 as a Potential Therapeutic Target in Colorectal Cancer

由 Ueno, Koji, Hiura, Mikako, Suehiro, Yutaka, Hazama, Shoichi, Hirata, Hiroshi, Oka, Masaaki, Imai, Kohzoh, Dahiya, Rajvir, Hinoda, Yuji
出版 2008

Long-fragment DNA as a potential marker for stool-based detection of colorectal cancer

由 ZHANG, YIBO, SUEHIRO, YUTAKA, SHINDO, YOSHITARO, SAKAI, KOUHEI, HAZAMA, SHOICHI, HIGAKI, SHINGO, SAKAIDA, ISAO, OKA, MASAAKI, YAMASAKI, TAKAHIRO
發表在 Oncol Lett (2015)

A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine For Patients With Advanced Pancreatic Cancer

由 Suzuki, Nobuaki, Hazama, Shoichi, Ueno, Tomio, Matsui, Hiroto, Shindo, Yoshitaro, Iida, Michihisa, Yoshimura, Kiyoshi, Yoshino, Shigefumi, Takeda, Kazuyoshi, Oka, Masaaki
出版 2014

Combined adjuvants of poly(I:C) plus LAG‐3‐Ig improve antitumor effects of tumor‐specific T cells, preventing their exhaustion

由 Kano, Yosuke, Iguchi, Takahiro, Matsui, Hiroto, Adachi, Keishi, Sakoda, Yukimi, Miyakawa, Tomoya, Doi, Shun, Hazama, Shoichi, Nagano, Hiroaki, Ueyama, Yoshiya, Tamada, Koji
發表在 Cancer Sci (2016)

Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer

由 TAMURA, KENJI, HAZAMA, SHOICHI, YAMAGUCHI, RUI, IMOTO, SEIYA, TAKENOUCHI, HIROKO, INOUE, YUKA, KANEKIYO, SHINSUKE, SHINDO, YOSHITARO, MIYANO, SATORU, NAKAMURA, YUSUKE, KIYOTANI, KAZUMA
發表在 Oncol Lett (2016)

Association of tumor necrosis factor-α polymorphism with chemotherapy-induced oral mucositis in patients with esophageal cancer

由 Sakamoto, Kazuhiko, Takeda, Shigeru, Kanekiyo, Shinsuke, Nishiyama, Mitsuo, Kitahara, Masahiro, Ueno, Tomio, Yamamoto, Shigeru, Yoshino, Shigefumi, Hazama, Shoichi, Okayama, Naoko, Nagano, Hiroaki
發表在 Mol Clin Oncol (2017)

Determining the protective characteristics and risk factors for the development of anastomotic leakage after low anterior resection for rectal cancer

由 Suzuki, Nobuaki, Yoshida, Shin, Tomochika, Shinobu, Nakagami, Yuki, Shindo, Yoshitaro, Tokumitsu, Yukio, Iida, Michihisa, Takeda, Shigeru, Hazama, Shoichi, Ueno, Tomio, Nagano, Hiroaki
發表在 Surg Today (2020)

Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET st...

由 Soda, Hitoshi, Maeda, Hiromichi, Hasegawa, Junichi, Takahashi, Takao, Hazama, Shoichi, Fukunaga, Mutsumi, Kono, Emiko, Kotaka, Masahito, Sakamoto, Junichi, Nagata, Naoki, Oba, Koji, Mishima, Hideyuki
發表在 BMC Cancer (2015)

Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin...

由 Nagasaka, Takeshi, Mishima, Hideyuki, Sawaki, Akira, Shimokawa, Mototsugu, Inukai, Michio, Shinozaki, Katsunori, Tanioka, Hiroaki, Nasu, Junichiro, Nishina, Tomohiro, Hazama, Shoichi, Okajima, Masazumi, Yamaguchi, Yoshiyuki
發表在 BMJ Open (2016)

Efficacy of CapeOX plus Cetuximab Treatment as a First-Line Therapy for Patients with Extended RAS/BRAF/PIK3CA Wild-Type Advanced or Metastatic Colorectal Cancer

由 Iwamoto, Shigeyoshi, Maeda, Hiromichi, Hazama, Shoichi, Oba, Koji, Okayama, Naoko, Suehiro, Yutaka, Yamasaki, Takahiro, Suzuki, Nobuaki, Nagano, Hiroaki, Sakamoto, Junichi, Mishima, Hideyuki, Nagata, Naoki
發表在 J Cancer (2018)

Genomic profiles of colorectal carcinoma with liver metastases and newly identified fusion genes

由 Oga, Takafumi, Yamashita, Yoshihiro, Soda, Manabu, Kojima, Shinya, Ueno, Toshihide, Kawazu, Masahito, Suzuki, Nobuaki, Nagano, Hiroaki, Hazama, Shoichi, Izumiya, Masashi, Koike, Kazuhiko, Mano, Hiroyuki
發表在 Cancer Sci (2019)

Is there diversity among UGT1A1 polymorphism in Japan?

由 Kobayashi, Michiya, Hazama, Shoichi, Takahashi, Kenichi, Oba, Koji, Okayama, Naoko, Nishioka, Mitsuaki, Hinoda, Yuji, Oka, Masaaki, Okamoto, Ken, Maeda, Hiromichi, Nakamura, Daisuke, Sakamoto, Junichi, Mishima, Hideyuki
出版 2012